Phase 1Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
A Single Center, Multiple Dose, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
- Sponsor
- TIXiMED, Inc. (Industry)
- Enrolment
- 18 planned
- Conditions
- Health Adult Subjects; Obesity & Overweight
- Interventions
- TIX100; Placebo
- Ages
- adults, older adults
- Registry
- NCT07675590
Full record on ClinicalTrials.gov
From the registry
Randomized, Placebo-controlled Study to determine the safety and tolerability of multiple oral doses of TIX100 administered daily for 28 days to otherwise healthy overweight/obese subjects.
Primary outcomes
- Safety and Tolerability
History
Study completion expected
Primary completion
Last registry update
Registered
Started